Core Laboratories Inc. (NYSE:CLB) Stock Position Increased by Disciplined Growth Investors Inc. MN

Disciplined Growth Investors Inc. MN increased its position in Core Laboratories Inc. (NYSE:CLB) by 26.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,653,591 shares of the oil and gas company’s stock after buying an additional 1,192,871 shares during the quarter. Core Laboratories comprises approximately 2.0% of Disciplined Growth Investors Inc. MN’s holdings, making the stock its 24th largest position. Disciplined Growth Investors Inc. MN owned approximately 12.04% of Core Laboratories worth $104,761,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Headlands Technologies LLC bought a new stake in Core Laboratories in the second quarter worth about $36,000. nVerses Capital LLC acquired a new position in shares of Core Laboratories in the 3rd quarter worth approximately $48,000. GAMMA Investing LLC raised its holdings in shares of Core Laboratories by 33.0% in the 3rd quarter. GAMMA Investing LLC now owns 5,885 shares of the oil and gas company’s stock worth $109,000 after purchasing an additional 1,460 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Core Laboratories by 11.9% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 600 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in Core Laboratories by 12.8% during the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock worth $137,000 after buying an additional 767 shares in the last quarter. Institutional investors own 97.81% of the company’s stock.

Wall Street Analyst Weigh In

CLB has been the topic of several recent research reports. Citigroup decreased their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research report on Thursday, October 31st. StockNews.com upgraded Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $17.00.

Core Laboratories Stock Performance

Shares of CLB opened at $19.36 on Tuesday. Core Laboratories Inc. has a one year low of $13.82 and a one year high of $25.13. The company has a 50-day moving average of $19.67 and a two-hundred day moving average of $19.65. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. The stock has a market cap of $908.72 million, a price-to-earnings ratio of 29.78, a PEG ratio of 1.30 and a beta of 2.35.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The firm had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. During the same quarter last year, the business posted $0.22 EPS. The company’s revenue was up 7.2% on a year-over-year basis. On average, equities research analysts expect that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.21%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s payout ratio is 6.15%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.